Detalhe da pesquisa
1.
Previous radiotherapy improves treatment responses and causes a trend toward longer time to progression among patients with immune checkpoint inhibitor-related adverse events.
Cancer Immunol Immunother
; 72(10): 3337-3347, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37486396
2.
Hot dots - which nodes should be removed in sentinel lymph node biopsy for melanoma?
Acta Oncol
; 62(9): 1021-1027, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37493624
3.
Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor.
Acta Oncol
; 61(10): 1263-1267, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-36307938
4.
Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy.
Blood
; 134(4): 353-362, 2019 07 25.
Artigo
Inglês
| MEDLINE | ID: mdl-31101627
5.
Different expression of BRAFV600E, ALK and PD-L1 in melanoma in children and adolescents: a nationwide retrospective study in Finland in 1990-2014.
Acta Oncol
; 60(2): 165-172, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-32815748
6.
Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients.
Cancer Immunol Immunother
; 69(5): 717-730, 2020 May.
Artigo
Inglês
| MEDLINE | ID: mdl-32036449
7.
Limited-duration anti-PD-1 therapy for patients with metastatic melanoma.
Acta Oncol
; 59(4): 438-443, 2020 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-32000554
8.
Nivolumab in previously untreated melanoma without BRAF mutation.
N Engl J Med
; 372(4): 320-30, 2015 Jan 22.
Artigo
Inglês
| MEDLINE | ID: mdl-25399552
9.
Intra-patient evolution of tumor microenvironment in the pathogenesis of treatment-naïve metastatic melanoma patients.
Acta Oncol
; 62(9): 1008-1013, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37624703
10.
Selective internal radiation therapy (SIRT) as treatment for hepatic metastases of uveal melanoma: a Finnish nation-wide retrospective experience.
Acta Oncol
; 57(10): 1373-1380, 2018 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-29683787
11.
Metastatic uveal melanoma managed with best supportive care.
Acta Oncol
; 60(1): 135-139, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-32960119
12.
Long-term prognostic value of sentinel lymph node tumor burden in survival of melanoma patients.
Acta Oncol
; 60(6): 803-807, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33656957
13.
[Adverse effects of new immunologic drugs for melanoma and their management in adult patients]. / Uusien immunologisten melanoomalääkkeiden haittavaikutukset ja niiden hallinta.
Duodecim
; 132(1): 45-52, 2016.
Artigo
Finlandês
| MEDLINE | ID: mdl-27044180
14.
Benefit of adjuvant interferon alfa-2b (IFN-α) therapy in melanoma patients with high serum MMP-8 levels.
Cancer Immunol Immunother
; 64(2): 173-80, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25319807
15.
Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma.
Acta Oncol
; 59(3): 310-314, 2020 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-31564175
16.
Determinants of Long-Term Survival in Metastatic Choroidal and Ciliary Body Melanoma.
Am J Ophthalmol
; 246: 258-272, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36328199
17.
Early clinical experience with a degraded 4 MeV electron beam in radiotherapy of superficial basal cell carcinoma.
Phys Imaging Radiat Oncol
; 27: 100487, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37705728
18.
Antibiotic Treatment is an Independent Poor Risk Factor in NSCLC But Not in Melanoma Patients Who had Received Anti-PD-1/L1 Monotherapy.
Clin Lung Cancer
; 24(4): 295-304, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36774235
19.
Single-cell characterization of anti-LAG-3 and anti-PD-1 combination treatment in patients with melanoma.
J Clin Invest
; 133(6)2023 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36719749
20.
Two different durations of adjuvant therapy with intermediate-dose interferon alfa-2b in patients with high-risk melanoma (Nordic IFN trial): a randomised phase 3 trial.
Lancet Oncol
; 12(2): 144-52, 2011 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-21256809